Efficacy and Safety of Vorapaxar by Intensity of Background Lipid‐Lowering Therapy in Patients With Peripheral Artery Disease: Insights From the TRA2P‐TIMI 50 Trial

BACKGROUND: Patients with peripheral artery disease are at increased risk of both major adverse cardiovascular events (MACEs) and limb events. The pathobiology of limb events is likely multifactorial. Observational studies suggest a benefit of statin therapy for reducing the risk of limb ischemic ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilchrist, Ian C., Morrow, David A., Creager, Mark A., Olin, Jeffrey W., Scirica, Benjamin M., Goodrich, Erica L., Bonaca, Marc P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751872/
https://www.ncbi.nlm.nih.gov/pubmed/34622665
http://dx.doi.org/10.1161/JAHA.121.021412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751872/
https://www.ncbi.nlm.nih.gov/pubmed/34622665
http://dx.doi.org/10.1161/JAHA.121.021412

Ejemplares similares